Aims/hypothesis Epithelium-mesenchyme interactions play a major role in pancreas development. Recently, we demonstrated that embryonic pancreatic mesenchyme enhanced progenitor cell proliferation but inhibited endocrine cell differentiation. Here, we investigated the role played by sulphated proteoglycans, which are known to be essential to embryonic development, in this inhibitory effect. Materials and methods We first determined the expression of the genes encoding glypicans, syndecans and the main glycosaminoglycan chain-modifying enzymes in immature embryonic day (E) 13.5 and more differentiated E17.5 rat pancreases. Next, using an in vitro model of pancreas development, we blocked the action of endogenous sulphated proteoglycans by treating embryonic pancreases in culture with chlorate, an inhibitor of proteoglycan sulphation, and examined the effects on pancreatic endocrine cell differentiation. Results We first showed that expression of the genes encoding glypicans 1, 2, 3 and 5 and heparan sulphate 2-sulfotransferase decreased between E13.5 and E17.5. We next found that alteration of proteoglycan action by chlorate blocked the inhibitory effect of the mesenchyme on endocrine differentiation. Chlorate-treated pancreases exhibited a dramatic increase in beta cell number in a dose-dependent manner (169-and 375-fold increase with 30 mmol/l and 40 mmol/l chlorate, respectively) and in alpha cell development. Insulin-positive cells that developed in the presence of chlorate exhibited a phenotype of mature cells with regard to the expression of the following genes: pancreatic and duodenal homeobox gene 1 (Pdx1), proprotein convertase subtilisin/kexin type 1 (Pcsk1; previously known as pro-hormone convertase 1/3), proprotein convertase subtilisin/kexin type 2 (Pcsk2; previously known as pro-hormone convertase 2) and solute carrier family 2 (facilitated glucose transporter), member 2 (Slc2a1; previously known as glucose transporter 2). Finally, we showed that chlorate activated endocrine cell development by inducing neurogenin 3 (Neurog3) expression in early endocrine progenitor cells. Conclusions/interpretation We demonstrated that sulphated proteoglycans control pancreatic endocrine cell differentiation. Understanding the mechanism by which sulphated proteoglycans affect beta cell development could be useful in the generation of beta cells from embryonic stem cells. heparan-sulphate-6-sulfotransferase HSPG heparan sulphate proteoglycans Diabetologia (2007) 50:585-595 
Introduction
The mature pancreas contains two types of tissue: endocrine islets of cells that produce hormones such as insulin (beta cells) and glucagon (alpha cells), and exocrine tissue whose acinar cells produce enzymes (e.g. carboxypeptidase) secreted via the pancreatic ducts into the intestine. The pancreas originates from the dorsal and ventral regions of the foregut endoderm directly posterior to the stomach. Research conducted in the last few years has shed light on the processes controlling pancreatic endocrine cell development. Studies of genetically engineered mice identified a hierarchy of transcription factors regulating pancreas organogenesis and islet cell differentiation [1, 2] . The endodermal region committed to a pancreatic fate expresses the transcription factor insulin promoter factor 1, homeodomain transcription factor/pancreatic and duodenal homeobox gene 1 (Ipf1/Pdx1) [3, 4] . The basic helixloop-helix factor neurogenin 3 (Neurog3, previously known as Ngn3) is then expressed in epithelial pancreatic progenitor cells prior to endocrine differentiation [5] . Neurog3 is necessary for pancreatic endocrine cell development, and Neurog3-deficient mice lack pancreatic endocrine cells [6] . Lineage tracing experiments have also provided direct evidence that Neurog3-expressing cells are islet progenitors [7] . Thus, Neurog3 is a valuable marker for monitoring pancreatic endocrine cell differentiation.
Permissive signals derived from adjacent mesodermal structures such as the notochord and dorsal aorta control the first step of pancreas development [8, 9] . Subsequently, the mesenchyme condenses around the underlying committed endoderm and the epithelial buds enlarge [10] . In the early 1960s, it was suggested that signals from the mesenchyme played an essential role in pancreatic cell development [11, 12] . However, the exact nature of the mesenchymal signals involved in controlling pancreatic cell proliferation and differentiation remained unknown. Recently, we demonstrated that pancreatic mesenchyme produces fibroblast growth factor (FGF)10, which is essential for maintaining the proliferative capacity of epithelial progenitor cells during pancreatic organogenesis [13] . Other studies showed that, although endocrine cells were able to develop in the absence of mesenchyme [14, 15] , pancreatic cell differentiation was tightly controlled by the mesenchyme [15, 16] . Subsequent evidence indicated that the mesenchyme negatively regulated specific steps of endocrine differentiation via direct cell-to-cell contact with the pancreatic epithelium [16, 17] .
Proteoglycans are composed of a core protein covalently linked to sulphated glycosaminoglycan chains such as heparan sulphate or chondroitin sulphate. The structural diversity of proteoglycans stems from: (1) differential expression of genes encoding the core proteins; (2) specific glycosaminoglycan-chain modifications via epimerisation, N-deacetylation and several O-sulphations; and (3) the existence of tissue-specific isoforms of the enzymes involved in proteoglycan biosynthesis [18, 19] .
Heparan sulphate proteoglycans (HSPGs) and chondroitin sulphate proteoglycans (CSPGs) are the two main proteoglycans [20] [21] [22] . HSPGs are produced at the cell surface and within the extracellular matrix. At the cell surface, heparan sulphate chains are attached to the transmembrane syndecan and glycosyl-phosphatidylinositol-anchored glypican core proteins. HSPGs interact with several signalling molecules and modulate ligand-receptor interactions, playing an essential role in development [20, 23, 24] . Recent studies have focused on the role of HSPGs in the development of many organs. For example, experiments in which chlorate was used to alter HSPGs have established the importance of HSPGs for brain and kidney development [25, 26] .
Little is known about the production and role of proteoglycans during pancreas development. To address this issue, we first determined the relative abundance of glypicans, syndecans and enzymes involved in glycosaminoglycan-chain maturation in the embryonic rat pancreas at critical stages of development (embryonic day [E]13.5 and E17.5). Levels of expression of the genes encoding glypicans 1, 2, 3 and 5 were lower on E17.5 than on E13.5. Similarly, expression of heparan sulphate 2-sulfotransferase 1 (Hs2st1) was lower on E17.5. We next performed experiments to determine whether proteoglycans were involved in epithelium-mesenchyme interactions during pancreas development. We determined that sulphated proteoglycans were located in the basement membrane of the pancreatic epithelium and in the mesenchyme.
Using an in vitro model of pancreas development, we showed that altering endogenous sulphated proteoglycans with the sulphation inhibitor chlorate abolished the inhibitory effect of the mesenchyme on endocrine cell development, inducing a dramatic increase in beta cell development. Finally, we demonstrated that the alpha and beta cell increase observed in chlorate-treated pancreas was related to induction of Neurog3.
Materials and methods
Animals and pancreatic dissection Pregnant Wistar rats were purchased from the Janvier breeding centre (CERJ, LeGenet, France). The first day postcoitum was taken as E0.5. Pregnant rats were killed with CO 2 asphyxiation according to guidelines issued by the French Animal Care Committee. Dorsal pancreatic buds from E13.5 rat embryos were prepared, and their epithelium was separated from the surrounding mesenchyme as described previously [15, 17] .
Organ culture Dorsal pancreatic rudiments with or without their mesenchyme were embedded, in four-well plates, in 500 μl of collagen gel consisting of 10% RPMI 10X (Invitrogen, Cergy-Pontoise, France), 80% type I rat-tail collagen (3 mg/ml; Institut Jacques Boy, Paris, France) and 10% sodium bicarbonate in 0.1 mol/l NaOH, as previously described [15, 17] . The pancreases were then grown in RPMI-1640 medium (Invitrogen) supplemented with 100 U/ ml penicillin, 100 μg/ml streptomycin, 10 mmol/l HEPES, 2 mmol/l L-glutamine, 1× non-essential amino acids (Invitrogen) and 10% heat-inactivated fetal calf serum (HyClone, Logan, UT, USA). Sodium chlorate, sodium sulphate, sodium chloride (Sigma, Paris, France) or chondroitinase ABC (Seikagaku, Tokyo, Japan) was added to the media daily in various concentrations. The cultures were incubated at 37°C in a humidified atmosphere composed of 95% air and 5% CO 2 .
Immunohistochemistry and surface quantification At the end of the 7-day culture period, the pancreatic rudiments were fixed in 10% formalin, pre-embedded in agarose gel (4% of type VII low-gelling-temperature agarose [Sigma] in water) and embedded in paraffin. Immunohistochemistry was performed on 4-μm paraffin sections as previously described [17] . The primary antibodies were mouse antihuman insulin (1/2,000; Sigma), rabbit anti-carboxypeptidase A (1/600; Biogenesis, Kidlington, Oxford, UK), mouse anti-porcine vimentin (1/50 clone V9; Dako, Trappes, France,) and rabbit anti-human PDX1 (1/1,000) [27] . The fluorescent secondary antibodies were fluorescein anti-rabbit antibody (1/200; Jackson Immunoresearch, Baltimore, MD, USA), fluorescein goat anti-rabbit Alexa Fluor 488 (1/400; Invitrogen) and Texas Red anti-mouse antibody (1/200; Jackson). Photographs were taken using a fluorescence microscope (Leitz DMRB; Leica, Ruel-Malmaison, France). For each pancreatic tissue, all sections were digitised using a cooled tri-CCD camera (C4742-95; Hamamatsu, Middlesex, NJ, USA). All images were taken at the same magnification and alternate sections were examined to avoid counting the same cell twice. On each image, the surface occupied by insulin-positive cells was quantified using Openlab 2.2.5 (Scanalytics, Billerica, MA, USA) and the surface areas per section were summed to obtain the total surface area per rudiment.
Semi-quantitative RT-PCR Total RNAs were prepared from E13.5 and E17.5 pancreases using a kit (RNeasy Microkit; Qiagen, Paris, France). Isolated RNA was treated with Dnase I to eliminate genomic contamination and reverse-transcribed with SuperScript reverse transcriptase (Invitrogen) using random hexamers (Invitrogen). The Electronic supplementary material (ESM) Table 1 lists the oligonucleotides used for amplification of glypicans-1, -2, -3, -4, -5; syndecans-1, -2, -3, -4; N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 (Ndst1); Hs2st1; heparan-sulphate-6-sulfotransferase 1 and 2 (Hs6st1, Hs6st2); and peptidylpropyl isomerase A (cyclophilin a) (Ppia). Ppia was used as the internal PCR control. Each of the 25, 30 and 35 amplification cycles consisted of a 30-s denaturation step at 94°C followed by a 30-s annealing step at 55°C then by a 30-s extension step at 72°C. The amplification products were separated on 2% agarose gel and photographed.
Real-time PCR To determine the transcript level of insulin 2, glucagon, Neurog3, proprotein convertase subtilisin/kexin type 1 (Pcsk1; previously known as pro-hormone convertase 1/3), proprotein convertase subtilisin/kexin type 2 (Pcsk2; previously known as pro-hormone convertase 2) and solute carrier family 2 (facilitated glucose transporter), member 2 (Slc2a2; previously known as glucose transporter 2 [Glut2]), we performed real-time PCR in pancreatic rudiments before (E13.5) and after 1, 3, 5 and 7 days of culture, with and without sodium chlorate 50 mmol/l, using a real-time PCR System (7300 Fast; Applied Biosystems, Paris, France). We prepared RNA and performed reverse transcription of 250 ng of each RNA sample as described above. The cDNA thus obtained was diluted to 1/20, and 5 μl of the dilution was used for each PCR. Each PCR was run using Taqman universal PCR master mix (Applied Biosystems) with primers and Taqman-labelled probes specific for each gene (Applied Biosystems), following the universal thermal cycling protocol (10 min at 95°C followed by 40 cycles of 15 s at 95°C and 1 min at 65°C). Ppia and E16.5 pancreas cDNA were used as the endogenous control and calibrator sample, respectively. The data were analysed using the comparative cycle threshold method [28] .
Alcian Blue staining Alcian Blue staining was performed using a modified protocol [29] on 4-μm paraffin sections. Briefly, sections were rehydrated and stained overnight at room temperature in a solution of 0.5 g/l aluminium sulphate (Sigma) and 10 g/l Alcian Blue (Flucka-Sigma). The sections were counterstained with Fast Red.
Statistical analysis Results are presented as mean±SD. Statistical analyses were performed using Student's t test.
Results
Genes encoding the proteoglycan core proteins and enzymes involved in glycosaminoglycan maturation are differentially expressed during early pancreas development
To determine the expression pattern of genes encoding proteoglycans during pancreas development, we used semiquantitative RT-PCR to evaluate the expression of genes encoding members of the two main cell-surface HSPG families, namely transmembrane syndecans and glycosylphosphatidylinositol-anchored glypicans, in immature embryonic pancreases (E13.5) and in pancreases at a more differentiated stage (E17.5). The results showed that syndecans 1-4 and glypicans 1-5 were expressed in the developing pancreas (Fig. 1a,b) . No major differences were found in the levels of expression genes encoding syndecans 1-4 between E13.5 and E17.5 (Fig. 1a) . In contrast, expression of genes encoding glypicans 1, 2, 3 and 5 was markedly lower on E17.5 than on E13.5 (Fig. 1b) .
We next assessed the expression of genes encoding several enzymes involved in N-deacetylation and sulphation of glycosaminoglycan chains (Fig. 1c) . We found that Ndst1, Hs2st1 and the two isoforms of Hs6st (Hs6st1 and Hs6st2) were expressed in pancreases at both E13.5 and E17.5 (Fig. 1c) . Hs6st3 transcripts were not detected at either stage (data not shown), in keeping with results obtained using embryonic mouse pancreas [30] . Interestingly, Hs2st1 expression was far lower at E17.5 than at E13.5 (Fig. 1c) .
Sulphated proteoglycans are localised in the epithelial basement membrane and in the mesenchyme To determine whether sulphated proteoglycans (heparan sulphate and chondroitin sulphate) were produced by epithelial and/or mesenchymal cells in the embryonic pancreas, we stained sections of E16.5 rat pancreases with Alcian Blue [29] . As shown in Fig. 2 , highly sulphated proteoglycans were detected in the epithelial basement membrane (Fig. 2a) and in the mesenchyme surrounding the epithelium (Fig. 2b) . No sulphated proteoglycans were detected in the pancreatic epithelium (Fig. 2a,b) .
Sodium chlorate induces beta cell differentiation in a dose-dependent manner When E13.5 pancreatic epithelium depleted of its surrounding mesenchyme was cultured for 7 days in collagen gel, beta cell differentiation occurred, leading to positive immunostaining for insulin (Fig. 3a) . In contrast, when E13.5 epithelium was grown with its surrounding mesenchyme under the same conditions, only a few scattered beta cells developed and most of the epithelial cells differentiated into acinar tissue that stained for carboxypeptidase-A (Fig. 3b) . We hypothesised that sulphated proteoglycans mediated the inhibitory effect of the mesenchyme on beta cell differentiation. To investigate this hypothesis, we cultured whole pancreatic E13.5 rudiments for 7 days with increasing concentrations of sodium chlorate, an inhibitor Fig. 1 Expression of genes encoding syndecans, glypicans and enzymes involved in glycosaminoglycan maturation during pancreas development. Semi-quantitative RT-PCR, in rat embryonic pancreas at E13.5 and E17.5, of: a syndecans-1,-2,-3 and -4; b glypicans-1,-2,-3, -4 and -5; and c N-deacetylase/N-sulfotransferase-1 (Ndst1), heparan sulphate-2-sulfotransferase 1 (Hs2st1) and the two isoforms of heparan sulphate-6-sulfotransferase (Hs6st1 and Hs6st2). The cDNAs were subjected to 25, 30 or 35 amplification cycles and loaded on 2% agarose gel. The housekeeping gene Ppia was used as an internal control. Glypicans-1, -2, -3 and -5, and Hs2st1 are developmentally regulated between E13.5 and E17.5 of glycosaminoglycan sulphation. Sodium chlorate is known to act as a sulphate analogue, blocking the formation of the sulphate donor 3′-phosphoadenosine 5′-phosphosulphate by competing with sulphate [31, 32] . After 7 days of culture, and in contrast to untreated pancreases (Fig. 3b) , a large number of insulin-containing cells were observed in the pancreases treated with chlorate 50 mmol/l (Fig. 3f) . Insulin-containing cells also developed when pancreases were treated with 40 or 30 mmol/l chlorate (Fig. 3d,e) . With 20 mmol/l chlorate (Fig. 3c ) or without chlorate (Fig. 3b) , very few insulin-containing cells were detected. To further confirm these results, quantitative analysis was performed. As shown in Fig. 3i , the development of insulin-positive cells occurred with chlorate 30 mmol/l, increased with 40 mmol/l and reached a plateau with chlorate 50 mmol/l. To check that beta cell differentiation observed in pancreatic rudiments cultured with chlorate was not due to osmotic variations, E13.5 rat pancreatic rudiments were grown for 7 days in medium containing NaCl, 40 or 50 mmol/l. Under these conditions, no insulin-positive cells were found after 7 days of culture (Fig. 3g,h ). Moreover, chlorate treatment induced a dramatic increase in glucagon (Gcg) expression (Fig. 3j) without major effects on acinar cell development (data not Fig. 3 Effect of chlorate on endocrine development in rat embryonic pancreas. E13.5 rat embryonic pancreatic epithelia (a) or whole pancreases (b-h) were cultured for 7 days and the tissues were analysed by immunohistochemistry using antibodies to insulin (red) and carboxypeptidase A (green). Various concentrations of sodium chlorate were added as follows: b 0 mmol/l; c 20 mmol/l; d 30 mmol/l; e 40 mmol/l; and f 50 mmol/l. g, h NaCl was added at concentrations of 40 mmol/ l and 50 mmol/l respectively. Scale bar=25 μm. i Quantification of the area occupied by insulin-positive cells in pancreatic rudiments cultured for 7 days with or without various concentrations of chlorate. j Quantification by real-time PCR of glucagon transcripts in E13.5 pancreases cultured for 7 days with or without chlorate 50 mmol/l. Each data point represents the mean±SD of at least three pancreatic rudiments. ***p<0.001; **p<0.01 Fig. 2 Location of sulphated proteoglycans in rat embryonic pancreas. Sections of E16.5 pancreas were stained with Alcian Blue, which labels sulphated proteoglycans. A strong signal was present in the basement membrane of the epithelium (black arrows) (a) and within the mesenchyme (b). Note the absence of signal within the epithelium. Mes, mesenchyme; Ep, epithelium. Scale bar=25 μm shown). Taken together, these findings indicate that proteoglycan alteration by chlorate activated endocrine cell development.
Alteration of chondroitin sulphate proteoglycan results in weak beta cell differentiation Chlorate treatment acts on both HSPG and CSPG sulphation. To investigate the potential role of CSPG in beta cell differentiation, we grew E13.5 pancreas rudiments (epithelium plus mesenchyme) for 7 days with various concentrations of chondroitinase ABC, an enzyme that selectively degrades chondroitin sulphate-glycosaminoglycan chains. Under these conditions, a small number of insulin-positive cells developed (Fig. 4a vs c,d ) and tended to form small clusters. However, the number of beta cells was small compared with cultures with chlorate.
Characterisation of the insulin-positive cells that developed with chlorate treatment
To further characterise the insulin-positive cells that developed with chlorate, we determined whether they produced markers that are found in mature beta cells and are important for beta cell function. Immunohistochemistry showed that insulin-positive cells that had developed in the presence of chlorate produced the transcription factor PDX1 (Fig. 5a-c) . Next, we used real-time RT-PCR to evaluate the expression of three beta cell genes, Pcsk1, Pcsk2 and Slc2a2, in pancreatic rudiments grown with or without chlorate. As shown in Fig. 5d-f , chlorate treatment dramatically increased the expression of Pcsk1, Pcsk2 and Slc2a2 mRNA compared with untreated pancreases. Taken together, the findings showed that the insulin-positive cells developed during 7 days of culture with chlorate exhibited the phenotype of mature beta cells.
Proteoglycan alteration by chlorate does not affect the mesenchyme As beta cell formation was similar in whole pancreatic rudiments (epithelium plus mesenchyme) treated with chlorate and in epithelium separated from its mesenchyme (Fig. 3a vs e) , we looked for effects of chlorate on the mesenchyme. To this end, we performed immunostaining with vimentin antibody, a marker of mesenchymal tissue. As shown in Fig. 6a vs b, vimentin-positive cells were present in rudiments grown with or without chlorate. Thus, the effect of chlorate on endocrine cell development was not related to specific destruction of mesenchymal cells.
Reversal by sulphate blocks beta cell development
To confirm that the effect of chlorate on beta cell development was due to inhibition of glycosaminoglycan sulphation, we investigated the ability of exogenous sulphate to block chlorate-induced beta cell development. We cultured E13.5 pancreatic rudiments with chlorate 30 mmol/l plus sulphate 30 mmol/l. After 7 days of culture, the number of insulin-positive cells was far lower with than without exogenous sulphate (Fig. 7b vs c) , consistent with competitive inhibition of glycosaminoglycan sulphation by chlorate. Quantification showed that adding sulphate resulted in a fivefold decrease in the number of beta cells that developed (Fig. 7d) . These results indicated that the mesenchyme, which was not altered by chlorate treatment (see Fig. 6b ), was still functional, as shown by its ability to block endocrine differentiation in the rescue experiment.
Proteoglycan alteration activates alpha and beta cell differentiation by inducing Neurog3 expression Beta cells derive from pluripotent progenitor cells producing PDX1. The transcription factor Neurog3 is then expressed in a subpopulation of progenitor cells that subsequently develop into beta cells. We therefore investigated whether chlorate activated beta cell development at early stages by acting upstream of NEUROG3 or at later stages by acting downstream of NEUROG3. For this Fig. 4 Effect of chondroitinase on beta cell development of embryonic pancreas. E13.5 pancreas rudiments were cultured for 7 days without (a) and with chondroitinase ABC in concentrations of 100 mU/ml (b), 300 mU/ml (c) or 900 mU/ml (d). The tissues were examined by immunohistochemistry using antibodies against insulin (red) and carboxypeptidase A (green). Note that a small number of insulin-positive cells developed in the chondroitinase-treated rudiments. Scale bar=25 μm purpose, we used real-time RT-PCR to assess the expression of Neurog3 mRNA in immature E13.5 whole pancreases before and after 1, 3, 5 and 7 days of culture with and without chlorate 50 mmol/l. As shown in Fig. 8a , Neurog3 was weakly expressed on E13.5 (culture day 0). Without chlorate, Neurog3 expression was low at all timepoints, leading to absence of beta cell development as assessed by insulin mRNA expression (Fig. 8b) . In contrast, Neurog3 expression was rapidly induced (after 1 day of culture) in the presence of chlorate, increased further after 3 and 5 days of culture and decreased thereafter (Fig. 8a) . This Neurog3 induction was followed by endocrine cell development as assessed by insulin (Fig. 8b) and glucagon (Fig. 3j) mRNA expression. Thus, our results indicated that proteoglycan alteration activated endocrine cell development at early stages by acting upstream of NEUROG3.
Discussion
We report that sulphated proteoglycans play a crucial role in controlling pancreatic endocrine cell differentiation. We first showed that genes encoding cell-surface proteoglycan core proteins and the main enzymes involved in glycosaminoglycan maturation are produced in the developing pancreas in a regulated fashion. Then, we demonstrated that sulphated proteoglycans are involved in the inhibitory effect of mesenchyme on alpha and beta cell development.
Our results establish that genes encoding members of the transmembrane syndecans and glycosyl-phosphatidylinositol-anchored glypican families are expressed in the embryonic pancreas. Also expressed are genes encoding the enzymes involved in glycosaminoglycan maturation, such as Ndst1, Hs2st1 and the two isoforms of Hs6st (Hs6st1 and Hs6st2). These enzymes are involved in HSPG biosynthesis and their absence has major effects on development. For example, mice lacking Ndst1 exhibit cerebral hypoplasia, olfactory bulb agenesis, ocular defects and axon guidance errors [33] ; they die shortly after birth as a consequence of lung defects and respiratory distress [34] . Hs2st1 knockout mice exhibit bilateral renal agenesis, as well as skeletal and Fig. 5 Characterisation of beta cells that developed with chlorate. Pancreatic rudiments were cultured for 7 days with 40 mmol/l of chlorate then stained for both insulin (red) (a) and PDX1 (green) (b). Merged images (c) show the double labelling for insulin and PDX1. Note that insulin-positive cells are stained for PDX1. Scale bar=25 μm. d-f Pancreatic rudiments were cultured for 7 days with or without chlorate 50 mmol/l. RNAs were extracted, and the expression of d Pcsk1, e Pcsk2 and f Slc2a2 was examined using real-time PCR. Data are the means of three independent experiments ±SD; each experiment was performed in triplicate. ***p<0.001 Fig. 6 The mesenchyme is not affected by chlorate treatment. Sections of pancreatic rudiments cultured for 7 days without (a) or with chlorate 50 mmol/l (b) were stained for insulin plus carboxypeptidase-A (both revealed in green) and the mesenchymal marker, vimentin (red). Vimentin-positive cells were present in both chlorate-treated and untreated pancreases, with the same distribution. Scale bar=25 μm ocular defects, and die in the neonatal period [35] . Finally, zebrafish that are deficient in Hs6st1 and/or Hs6st2 have severe impairments in the development of muscle [36] and blood vessels [37] .
We showed that expression of genes encoding proteoglycans and enzymes involved in proteoglycan synthesis was regulated during pancreas development. Specifically, the expression of genes encoding glypicans 1, 2, 3 and 5 was higher at E13.5, an early stage of development, than at E17.5, a more differentiated stage. A decline in glypican expression during development has previously been demonstrated in the embryonic kidney, where HSPGs play a major role [26] . Our results show that, among the genes encoding glycosaminoglycan-modifying enzymes, Hs2st1 is developmentally regulated, in keeping with previous studies of the expression of the gene encoding glycosyl transferase in embryonic mouse pancreas [38] . This enzyme, which is involved in heparan sulphate chain initiation and elongation, reached a peak during epithelial cell proliferation (i.e. at the undifferentiated stage) and decreased as differentiation occurred. Taken together, these findings suggest an important role for proteoglycans during development.
We then investigated whether sulphated proteoglycans were involved in pancreas development. Normal pancreas development requires that pancreatic progenitor cells proliferate and subsequently differentiate into endocrine or exocrine cells [39] . It is now well established that signals from the embryonic pancreatic mesenchyme activate the proliferation of progenitor cells located in the epithelium and control their differentiation into endocrine and exocrine tissues [10, 40, 41] . Mesenchymal signals that activate the proliferation of progenitor epithelial cells are beginning to be characterised, with a major role being ascribed to members of the FGF family, such as FGF10 [13] . In contrast, the nature of the mesenchymal effectors involved in blocking or delaying endocrine cell differentiation [15] [16] [17] remains unclear, although studies indicate that direct cell-cell contact between the epithelium and the mesenchyme must occur [16, 17] . Here, we showed that: (1) sulphated proteoglycans are located in the epithelial basement membrane and mesenchyme; and (2) glypican expression is tightly regulated and decreased when pancreatic cell differentiation is activated. We therefore investi- gated whether altering proteoglycans affected the ability of the mesenchyme to block endocrine cell differentiation. For this purpose, we used an in vitro model of whole E13.5 rat embryonic pancreases cultured in collagen gel. This in vitro model was previously used to study the effects of mesenchymal signals on beta cell differentiation. Beta cell development occurred far later with than without mesenchyme [15, 17] , demonstrating that one function of the mesenchyme is to delay beta cell differentiation. This delay in beta cell differentiation seems crucial to the generation of a sufficient number of beta cells. Indeed, while early pancreatic progenitors proliferate at a fast rate [13] , proliferation decreases sharply once the cells differentiate into beta cells [42] . Accelerated beta cell differentiation in mice that lack the basic helix-loop-helix gene Hes1 [hairy and enhancer of split 1 (Drosophila)] results in inadequate growth of the pancreatic progenitor cell population, leading to severe pancreatic hypoplasia [43] . Delaying beta cell differentiation is therefore crucial to the development of an adequate beta cell population. This is in fact what happens during normal development when a specific region of the gut endoderm commits to pancreatic development as early as the eight-somite stage (E8 in mice, E10 in rats), whereas the first beta cells develop 5 days later (E13 in mice, E15 in rats). This 5-day period may serve to ensure expansion of the progenitor cell pool.
To evaluate the potential role of proteoglycans on beta cell differentiation, we used sodium chlorate to alter proteoglycan sulphation. This known inhibitor of glycosaminoglycan sulphation has been used successfully in vitro to demonstrate that sulphated proteoglycans are involved in the development of several organs including the kidney [26] , lung [29, 44] , neural tube [45] and brain [25] . In our study, defective sulphation of both HSPGs and CSPGs induced by chlorate produced a dramatic increase in the number of pancreatic endocrine cells that develop in vitro from E13.5 pancreas. This effect of chlorate is mesenchymedependent since it does not occur when the epithelium is cultured in absence of mesenchyme (data not shown).
The insulin-positive cells that developed in the presence of chlorate resembled mature beta cells with regard to the expression of genes encoding key molecules such as Pdx1, Pcsk1, Pcsk2 and Slc2a2 , which are crucial for normal beta cell function. We showed that chlorate activated pancreatic endocrine cell development by acting upstream of NEUROG3. Neurog3 is a transcription factor expressed in pancreatic progenitor cells and known to be necessary for pancreatic endocrine cell development [6, 7] . We previously demonstrated that mesenchyme substantially decreased the level of Neurog3 expression in vitro [17] . Here, we found that chlorate-induced alterations in proteoglycans abolished this inhibitory effect of the mesenchyme by acting upstream of NEUROG3. With chlorate, Neurog3 expression turned on rapidly (after 1 day of culture) and peaked after 3 days of culture. Neurog3 expression next turned off when beta cell development occurred, as reported in vivo [5, 17, 43] . Taken together, our results indicate that blocking Neurog3 induction by the mesenchyme requires sulphated proteoglycans. Specific degradation of chondroitin sulphate chains resulted in a low level of beta cell differentiation, suggesting that the inhibitory effect of the mesenchyme may act primarily via HSPGs rather than CSPGs.
Recently, we demonstrated that the mesenchyme represses Neurog3 expression via the NOTCH pathway [17] . Here we show that chlorate can block such a repressive effect of the mesenchyme, suggesting that chlorate, by altering proteoglycan sulphation, can perturb the NOTCH pathway. Such a hypothesis is supported by recent data indicating that in Drosophila, a reduction of a 3-O-sulfotransferase function leads to a neurogenic phenotype characteristic of NOTCH mutants [46] .
In conclusion, this study shows that proteoglycans are involved in mesenchyme-related blockade of endocrine cell development via a mechanism acting upstream of NEUROG3. This ability of the mesenchyme to block endocrine cell differentiation may explain the difficulties encountered in reproducibly generating beta cells from embryonic stem cells [47, 48] compared with generation of other cell types such as neurons [49] or cardiomyocytes [50] . It would now be of interest to determine whether proteoglycan modulation can induce beta cell development from embryonic stem cells.
